No Prescription |
 |
 | ||
|
Combantrin Pin Rid |
|
| ||
No Prescription » Prescription Drugs 4 » Combantrin Pin Rid This medication is used to treat intestinal worm infections such as pinworm roundworm and hookworm. Pyrantel belongs to a class of drugs known as anthelmintics. It works by making the worms unable to move (paralyzed) so that the body can remove them naturally.This drug is not recommended for use in children younger than 2 years unless directed by the doctor.How to use Pyrantel Pamoate OralShake the medication well before using. Take this medication by mouth with or without food or as directed by your doctor.Dosage is based on your weight and response to treatment. Depending on the type of worm infection you have your doctor may Online you to take the medication only once or for several days. Your doctor may also Online you to repeat the dose in 2 weeks.This medication may be taken with milk or fruit juice. It is not necessary to take a laxative before during or after taking this medication.What conditions does this medication treat?Pyrantel Pamoate Oral is used to treat the following:Infestation by Roundworms Pinworm Infection Infection caused by More than One Type of WormPyrantel Pamoate Oral may also be used to treat:Hookworm Infection caused by Ancylostoma Duodenale Hookworm Infection caused by Uncinaria Hookworms Hookworm Infection caused by Necator Americanus An Infection caused by Worms Moniliformis Parasite Buy Combantrin Pin Rid and other Prescription Drugs 4 products online at Medstore. Buy Online at Medstore - Click Here!
About Combantrin Pin Rid: Product Type: Prescription Drugs 4 Combantrin Chocolate Squares ( Pin-Rid Pin-X Generic Pyrantel Pamoate ) Combantrin (Pin-Rid Pin-X Generic Pyrantel Pamoate) Pin-Rid Pin-X Generic Pyrantel Pamoate 100mg 90mL(3 x 30mL) 30mL 4 Squares Pin-Rid Pin-X Generic Pyrantel Pamoate Combantrin
View more Prescription Drugs 4 No Prescription: NEW YORK, Oct. 5, 2011 /PRNewswire via COMTEX/ -- Reportlinker.com announces that a new market research report is available in its catalogue: European Pharmaceutical Market: Strategic Assessments of Leading Suppliers http://www.reportlinker.com/p0651431/European-Pharmaceutical-Market-Strategic-Assessments-of-Leading-Suppliers.html #utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication This report provides industry executives with strategically significant competitor information and analysis of the leading players in the European pharmaceutical market. The report provides a worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. Sales forecast for major drug categories: cardiovascular, gastrointestinal, antibiotic, CNS, respiratory, musculoskeletal, hormonal/genitourinary, dermatological, oncological, ophthalmic, and others. In addition, the report reviews major regulatory, technological, economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies. The companies analyzed in this report include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Wyeth.
| ||
